Eli Lilly posts strong Phase 3 win for Jaypirca combo in blood cancer trial
Benefits were consistent across all key subgroups, including patients previously treated with covalent BTK inhibitors
Benefits were consistent across all key subgroups, including patients previously treated with covalent BTK inhibitors
Highlights Mirvetuximab-based regimen promise
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
MoU aims to strengthen academia-industry collaboration in healthcare research and innovation
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems
Each program will rely on partnerships between Novartis teams and local networks—including health authorities, community organizations and private sector groups
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
Subscribe To Our Newsletter & Stay Updated